Control of IgG/Fc glycosylation: a comparison of oligosaccharides from chimeric human/mouse and mouse subclass immunoglobulin Gs.

Oligosaccharide profiles were obtained for chimeric mouse-human antibodies corresponding to each of the human IgG subclasses 1-4, and mouse IgG2b antibodies each expressed in the mouse J558L cell line. These antibodies have specificity for the NIP hapten and form a matched set of IgGs. An IgG4 chimeric antibody (B72.3) produced in the chinese hamster ovary (CHO-K1) cell line was also analysed for carbohydrate. Additionally aglycosylated mutants of this IgG4 (B72.3) and anti-NIP mouse IgG2b were analysed. The total lack of carbohydrate found in the aglycosylated site-directed mutants human chimeric IgG4 B72.3 (Asn 297-->Gln) and mouse IgG2b (Asn 297-->Ala) demonstrates that there are no N-glycosylation sites other than Asn 297. Therefore glycosylation profiles for all the IgGs analysed reflect carbohydrate attached to this site. Factors such as cell type (A), template direction by the IgG heavy chains (B) and culture conditions (C) are shown to influence IgG glycosylation profiles. (A) The anti-NIP IgG antibodies expressed by the J558L cell line may have one or two Gal (alpha 1-->3) Gal residues per oligosaccharide unit, indicative of the presence of (alpha 1-->3) galactosyl transferase in the J558L mouse cell line. (B) The galactosylation profiles obtained for the IgG heavy chains, in particular the preference for galactosylation of the Man (alpha 1-->6) arm rather than the Man (alpha 1-->3) arm, contrary to the beta-galactosyltransferase specificity, suggest that the polypeptide chain may act as a template to influence the extent of galactosylation and hence the proportions of each oligosaccharide incorporated. The IgG2 antibody does not display this galactosylation preference. (C) The extent of galactosylation appears to be influenced by the growth conditions, with the highest levels of galactosylation being found for IgG produced by cells grown in still cultures, rather than cells grown as ascites or in hollow fibre bioreactors. It is concluded that though the profile of glycosylation is controlled predominantly by the glycosylation activity of the cell in which the IgG is expressed, differences between the IgG heavy chain templates of the various subclasses and culture conditions can also influence glycosylation.

[1]  C. Blonk,et al.  In vitro production of monoclonal antibodies under serum-free conditions using a compact and inexpensive hollow fibre cell culture unit. , 1988, Journal of immunological methods.

[2]  R. Jefferis,et al.  A comparative study of the N-linked oligosaccharide structures of human IgG subclass proteins. , 1990, The Biochemical journal.

[3]  G. Sármay,et al.  A protein structural change in aglycosylated IgG3 correlates with loss of huFcγR1 and hufcγR111 binding and/or activation , 1990 .

[4]  E. Kabat,et al.  Antibody variable region glycosylation: position effects on antigen binding and carbohydrate structure. , 1991, The EMBO journal.

[5]  D. Burton,et al.  Human Fc gamma RI and Fc gamma RII interact with distinct but overlapping sites on human IgG. , 1991, Journal of immunology.

[6]  C. Goochee,et al.  The Oligosaccharides of Glycoproteins: Bioprocess Factors Affecting Oligosaccharide Structure and their Effect on Glycoprotein Properties , 1991, Bio/Technology.

[7]  M. Neuberger,et al.  Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies , 1987, The Journal of experimental medicine.

[8]  R. Townsend,et al.  Monosaccharide analysis of glycoconjugates by anion exchange chromatography with pulsed amperometric detection. , 1988, Analytical biochemistry.

[9]  M. Neuberger,et al.  Construction of novel antibodies by use of DNA transfection: design of plasmid vectors , 1986, Philosophical Transactions of the Royal Society of London. Series A, Mathematical and Physical Sciences.

[10]  J. Schlom,et al.  Characterization and biodistribution of recombinant and recombinant/chimeric constructs of monoclonal antibody B72.3. , 1989, Cancer research.

[11]  S. Morrison,et al.  Segmental flexibility and complement fixation of genetically engineered chimeric human, rabbit and mouse antibodies. , 1988, The EMBO journal.

[12]  H. Schachter,et al.  Control of glycoprotein synthesis. Bovine milk UDPgalactose:N-acetylglucosamine beta-4-galactosyltransferase catalyzes the preferential transfer of galactose to the GlcNAc beta 1,2Man alpha 1,3- branch of both bisected and nonbisected complex biantennary asparagine-linked oligosaccharides. , 1985, Biochemistry.

[13]  J. Deisenhofer.  Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution. , 1981, Biochemistry.

[14]  K. Weber,et al.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. , 1969, The Journal of biological chemistry.

[15]  R. Owens,et al.  Site-specific attachment to recombinant antibodies via introduced surface cysteine residues. , 1990, Protein engineering.

[16]  R. R. Robinson,et al.  Secretion of functional antibody and Fab fragment from yeast cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[17]  A. Shimizu,et al.  Structural and numerical variations of the carbohydrate moiety of immunoglobulin G. , 1982, Journal of immunology.

[18]  S. C. Hubbard.  Regulation of glycosylation. The influence of protein structure on N-linked oligosaccharide processing. , 1988, The Journal of biological chemistry.

[19]  R. Bligny,et al.  Xylose-containing common structural unit in N-linked oligosaccharides of laccase from sycamore cells , 1986 .

[20]  Charles F. Goochee,et al.  Environmental Effects on Protein Glycosylation , 1990, Bio/Technology.

[21]  K. Titani,et al.  The occurrence of mouse-type oligosaccharides in mouse-human chimeric immunoglobulin G. , 1989, Biochemical and biophysical research communications.

[22]  S. Shohet,et al.  Man, apes, and Old World monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells. , 1988, The Journal of biological chemistry.

[23]  H. Wigzell,et al.  Biological significance of carbohydrate chains on monoclonal antibodies. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[24]  S. Fujii,et al.  Structural heterogeneity of sugar chains in immunoglobulin G. Conformation of immunoglobulin G molecule and substrate specificities of glycosyltransferases. , 1990, The Journal of biological chemistry.

[25]  S Hase,et al.  Reexamination of the pyridylamination used for fluorescence labeling of oligosaccharides and its application to glycoproteins. , 1984, Journal of biochemistry.

[26]  Shigeru FujiiS,et al.  Structural Heterogeneity of Sugar Chains in Immunoglobulin G , 1990 .

[27]  G. Winter,et al.  The binding site for C1q on IgG , 1988, Nature.

[28]  D R Burton,et al.  Effector functions of a monoclonal aglycosylated mouse IgG2a: binding and activation of complement component C1 and interaction with human monocyte Fc receptor. , 1985, Molecular immunology.

[29]  C. Milstein,et al.  [1] Preparation of monoclonal antibodies: Strategies and procedures , 1981 .

[30]  R. Dwek,et al.  Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG , 1985, Nature.